The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPortmeirion Regulatory News (PMP)

Share Price Information for Portmeirion (PMP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 262.50
Bid: 255.00
Ask: 270.00
Change: -4.50 (-1.69%)
Spread: 15.00 (5.882%)
Open: 267.00
High: 267.00
Low: 262.50
Prev. Close: 267.00
PMP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Jan 2023 07:00

RNS Number : 4585M
Portmeirion Group PLC
12 January 2023
 

12 January 2023

Portmeirion Group PLC (the 'Group')

FY22 Trading Update

Strong second half and Christmas trading ahead of expectations

Portmeirion Group PLC, the designer, manufacturer and worldwide distributor of high quality homewares under the Portmeirion, Spode, Royal Worcester, Pimpernel, Wax Lyrical and Nambé brands, updates on full year trading for the 2022 financial year.

 

We are pleased to report a strong Christmas trading period with robust demand across our portfolio of consumer goods brands. As a result, FY22 sales are now expected to be at least £110 million, 4% ahead of 2021 and 4% ahead of consensus market expectations. Group sales are now 18% above pre-Covid 2019 levels.

 

We expect FY22 profit before taxation to be 10% above the prior year and now ahead of pre-Covid 2019 levels, with improved operating margins and in line with market expectations.

 

Mike Raybould, Chief Executive commented:

 

"I am delighted with our continued progress particularly given the much tougher wider economic environment. The sales outperformance benefits from the retranslation of US dollar sales at a lower rate (which benefits revenue but not profitability) and also a stronger than expected seasonal trading performance in our US market and continued momentum in South Korea. Our highly experienced teams continue to manage costs and successfully navigate the challenges of global supply chain disruption and ongoing effects of the war in Ukraine.

 

It is pleasing to see the benefit of the strategic and operational changes we are driving through our business. Our sales footprint is increasingly diversified, with the US our largest sales market and 75% of sales now outside the UK, higher online channel penetration and clear evidence that our unique brands continue to resonate strongly with our end customers. Portmeirion Botanic Garden celebrated its 50th year in 2022 and Spode Christmas Tree, first launched in 1938, remains a perennial US market favourite.

 

Whilst we remain cautious in our outlook for 2023 given the backdrop of expected weaker consumer demand, we believe that the Group is well placed for growth as conditions improve. We will continue to focus on our long term strategy of driving growth through greater customer reach via further geographical expansion, building online channels and leveraging our brands. We expect to improve operating margins further in 2023 through ongoing implementation of operational efficiencies, driving operating margin towards our longer-term target of more than 13%. In addition, we look forward to a number of exciting new product launches in 2023 as we seek to further leverage our brand portfolio, including our exciting Spode tableware and giftware collaboration with British interior designer, Kit Kemp."

 

The Company expects to announce preliminary results for the year ended 31 December 2022 on 23 March 2023.

 

Notes: This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR").

Enquiries:-

Portmeirion Group PLC:

 

 

Mike Raybould

+44 (0) 1782 743443

mraybould@portmeiriongroup.com

Chief Executive

David Sproston

 

+44 (0) 1782 743443

 

dsproston@portmeiriongroup.com

Group Finance Director

 

 

 

Hudson Sandler:

 

 

Dan de Belder

+44 (0) 207 796 4133

ddebelder@hudsonsandler.com

Nick Moore

 

nmoore@hudsonsandler.com

 

Panmure Gordon

(Nominated Adviser and Broker):

 

+44 (0) 207 886 2500

Freddy Crossley

Corporate Finance

Rupert Dearden

Corporate Broking

 

Singer Capital Markets

(Joint Broker):

 

+44 (0) 207 496 3000

Peter Steel

Investment Banking

Asha Chotai

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUARRROAUAAUR
Date   Source Headline
17th Apr 20247:00 amRNSAnnual Report & Accounts and Notice of AGM
4th Apr 20242:41 pmRNSHolding(s) in Company
27th Mar 20247:00 amRNSNotice of Investor Presentation
17th Jan 20247:00 amRNSFY23 Trading Update
28th Nov 20235:10 pmRNSHolding(s) in Company
22nd Nov 202311:03 amRNSHolding(s) in Company
19th Oct 20237:00 amRNSUS market product and marketing initiatives
28th Sep 202312:39 pmRNSHolding(s) in Company
18th Sep 202312:02 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSInterim Results
11th Sep 20237:00 amRNSNotice of Investor Presentation
8th Sep 20237:00 amRNSNotice of Interim Results
20th Jul 20237:00 amRNSTrading Update
12th Jun 20233:37 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSBoard Appointment
23rd May 20231:58 pmRNSAGM Resolutions
23rd May 20237:00 amRNSAGM Trading Statement
16th May 20237:00 amRNSNew Sustainability Strategy and Roadmap
3rd May 202311:39 amRNSGrant of Options
14th Apr 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
23rd Mar 20237:00 amRNSPreliminary Results
6th Mar 20237:00 amRNSNotice of Investor Presentation
27th Feb 20234:43 pmRNSHolding(s) in Company
24th Feb 20237:00 amRNSAppointment of Nomad and Joint Broker
23rd Feb 20237:00 amRNSAIM Rule 17 Schedule 2(g) Update
12th Jan 20237:00 amRNSTrading Update
3rd Nov 20227:00 amRNSAnnouncement of new design collaboration
13th Oct 20223:50 pmRNSHolding(s) in Company
26th Sep 20227:00 amRNSExercise of Options and PDMR Shareholdings
15th Sep 20227:00 amRNSInterim Results
8th Sep 20227:00 amRNSLaunch of new UK ecommerce sites
7th Sep 20227:00 amRNSInvestor Results Presentation
2nd Sep 20223:08 pmRNSNotice of Interim Results
15th Aug 20227:00 amRNSAcquisition of AromaWorks London
14th Jul 20227:00 amRNSTrading Update
7th Jul 20227:00 amRNSDirectorate Changes
1st Jul 202210:59 amRNSHolding(s) in Company
29th Jun 20223:18 pmRNSHolding(s) in Company
15th Jun 20223:08 pmRNSDirectors’ Dealings
19th May 20222:38 pmRNSAGM Resolutions
19th May 20227:00 amRNSAGM Trading Statement
12th May 202212:54 pmRNSHolding(s) in Company
26th Apr 20221:49 pmRNSGrant of Options
17th Mar 20227:00 amRNSPreliminary Results
7th Mar 20227:00 amRNSInvestor Results Presentation
24th Feb 20224:20 pmRNSAIM Rule 17 Schedule 2(g) Update
2nd Feb 202211:00 amRNSCapital Markets Day
12th Jan 20227:00 amRNSTrading Update
11th Nov 20217:15 amRNSTrading Update
14th Sep 20217:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.